Geographics
We are an USA-EU multinational
The ALIKO SCIENTIFIC is geographically distributed with its financial headquarters based in Paris, France, where it is publicly listed on the Paris Stock Exchange.
Its operational footprint extends internationally, with Ikonisys operating from New Haven, Connecticut, in the United States, and Hospitex headquartered in Florence, Italy.
This strategic distribution allows ALIKO to maintain a strong presence across key markets in Europe and North America, facilitating innovation and growth in the medical technology sector.
Its operational footprint extends internationally, with Ikonisys operating from New Haven, Connecticut, in the United States, and Hospitex headquartered in Florence, Italy.
This strategic distribution allows ALIKO to maintain a strong presence across key markets in Europe and North America, facilitating innovation and growth in the medical technology sector.
Company Profile
Ikonisys boasts a 23-year history of technological leadership in the US market, particularly within the highly specialized niche of FISH diagnostics for cancer detection.
In 2024, Ikonisys acquired 100% of Hospitex International, an SME that introduced groundbreaking innovations in LBC cytology, another specialized area of cancer diagnostics.
Under the name ALIKO SCIENTIFIC, Ikonisys SA now positions itself as the corporate headquarter responsible for the strategic, financial, and operational management of innovative companies and technologies dedicated to oncology diagnostics.
In 2024, Ikonisys acquired 100% of Hospitex International, an SME that introduced groundbreaking innovations in LBC cytology, another specialized area of cancer diagnostics.
Under the name ALIKO SCIENTIFIC, Ikonisys SA now positions itself as the corporate headquarter responsible for the strategic, financial, and operational management of innovative companies and technologies dedicated to oncology diagnostics.
BOARD OF DIRECTORS
AND MANAGEMENT
We are growing
Credibly innovate granular internal or "organic" sources whereas high standards in web-readiness. Energistically scale future-proof core competencies vis-a-vis impactful experiences.
CFO & Appointed CTOAlessandro Mauri
CDO & Appointed COOAlessandro Nosei
Board of Directors and Management
Our board of directors comprises seasoned industry leaders and experts, dedicated to steering our company towards innovation, strategic growth, and excellence in the medical device industry.
COO & Appointed CEOFrancesco Trisolini
BOARD OF DIRECTORS:Mario Mauri, Chairman
Roberto Rettani, Director
Vittorio Grazioli, Director
Alberto Calvo, Director
Pramod Srivastava, Director
Thomas Avolio, Director
Sara Polatti, Director
A SHORT REVIEW OF OUR HISTORYFrom a small scientific group
to a public company
01234567890012345678900123456789001234567890
Ikonisys was founded in
New Haven,
Connecticut, USA .
Start
01234567890012345678900123456789001234567890
FDA clearance
IKONISCOPE GEN1
launch
Research and development time
01234567890012345678900123456789001234567890
Market development
30 Ikoniscsope microscopes sold
Market penetration
01234567890012345678900123456789001234567890
New R&D releases
oncoFISH ALK and oncoFISH HER2 applications
Application development
01234567890012345678900123456789001234567890
Ikonisys goes public on the site
Euronext Growth Paris
Financial boost
01234567890012345678900123456789001234567890
Acquisition of
Hospitex International, Italy
The time of industrial synergies
01234567890012345678900123456789001234567890
Launch of
Ikoniscope Max, automatic digital microscope
Cutting-edge technological development
01234567890012345678900123456789001234567890
Ikonisys SA turns into the new group entity
ALIKO SCIENTIFIC
Next Generation Cancer Diagnostic
Passion for Science is our Core Value
In the medical device industry, continuous R&D is the cornerstone of innovation, driving the development of cutting-edge technologies that improve patient outcomes and healthcare efficiency.
Thinking our of the boxR&D
For Cancer Diagnostics
Our R&D strategy focus is centered on advancing cutting-edge technologies for cancer diagnostics, aiming to improve early detection, accuracy, and patient outcomes.
The underlying vision is the integration of diverse technologies into a single, unified approach, to create a comprehensive and efficient diagnostic platform.
The underlying vision is the integration of diverse technologies into a single, unified approach, to create a comprehensive and efficient diagnostic platform.
Academic and Industry Network
Collaborations with prestigious universities are a key aspect of fostering innovation and advancing research, particularly for companies and organizations in fields such as technology, healthcare, and scientific research.
Our Prestigious
Scientific Partnerships
UConn Health
The healthcare division of the University of Connecticut, encompassing a medical school, dental school, and hospital dedicated to patient care, education, and research.
Polytechnic University of Milan
Facilities with advanced equipment and qualified teams, dedicated to research and innovation, with experimentation, collaboration, and technology transfer activities.
TomaLab MIlan
A laboratory specializing in medical diagnostics and the development of innovative health technologies.
ImpactLab
A research initiative that evaluates and maximizes the societal and technological impact of scientific and industrial projects.
Get in touch
Come and visit our quarters or simply send us an e-mail: info@alikoscientific.com
Legal Headquarters
Aliko Scientific SA
rue de Caumartin,62
75009 Paris, France
rue de Caumartin,62
75009 Paris, France
Corporate Headquarters
Aliko Scientific Srl
Via dell'Ambrosiana, 22
20123 Milano, Italy
Via dell'Ambrosiana, 22
20123 Milano, Italy
Operating Headquarters
Aliko Scientific Srl
Via Massimo D'Antona, 17
50019 Sesto Fiorentino (FI), Italy
Via Massimo D'Antona, 17
50019 Sesto Fiorentino (FI), Italy
DISCOVER OUR GROUP
CONTACTS
Aliko Scientific SA (formerly Ikonisys SA)
62, rue de Caumartin
75009 Paris
Email: investor@alikoscientific.com
TVA : FR38899843239
RCS : 899 843 239 R.C.S. Paris
EORI: FR89984323900018
ALIKO SCIENTIFIC
IKONISYS
HOSPITEX
Copyright by Aliko Scientific SA (formerly Ikonisys SA). All rights reserved.